ES2087151T3 - Preparacion de composiciones complejas de liposomas y lipidos. - Google Patents

Preparacion de composiciones complejas de liposomas y lipidos.

Info

Publication number
ES2087151T3
ES2087151T3 ES90906530T ES90906530T ES2087151T3 ES 2087151 T3 ES2087151 T3 ES 2087151T3 ES 90906530 T ES90906530 T ES 90906530T ES 90906530 T ES90906530 T ES 90906530T ES 2087151 T3 ES2087151 T3 ES 2087151T3
Authority
ES
Spain
Prior art keywords
liposomes
compounds
lipids
preparation
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90906530T
Other languages
English (en)
Inventor
Francis C Szoka Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Application granted granted Critical
Publication of ES2087151T3 publication Critical patent/ES2087151T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORMULACIONES DE COMPUESTOS DE PARTICULAS LIPIDICAS Y LIPOSOMAS SE PREPARAN DISOLVIENDO EN UNA SOLUCION DE LIPIDOS FORMADORES DE LIPOSOMAS EN UN SOLVENTE APROTICO COMO EL DMSO, QUE CONTIENE OPCIONALMENTE UNA CANTIDAD SOLUBILIZABLE EN LIPIDOS DE UN ALCANOL INFERIOR, E INYECTANDO LA SOLUCION RESULTANTE EN UNA SOLUCION ACUOSA. LA SUSPENSION DE PARTICULA LIPIDICA O DE LIPOSOMAS RESULTANTE PUEDE ENTONCES DIALIZARSE O BIEN CONCENTRARSE. ESTE METODO ES ESPECIALMENTE UTIL PARA COMPUESTOS QUE SON POCO SOLUBLES EN SOLUCION ACUOSA, PERO ES GENERALMENTE UTIL PARA CUALQUIER COMPUESTO O COMBINACION DE COMPUESTOS QUE PUEDEN DISOLVERSE EN EL SOLVENTE APROTICO O LA MEZCLA DE SOLVENTE APROTICO/ALCANOL INFERIOR.
ES90906530T 1989-03-31 1990-03-28 Preparacion de composiciones complejas de liposomas y lipidos. Expired - Lifetime ES2087151T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33260989A 1989-03-31 1989-03-31
US33405589A 1989-04-05 1989-04-05

Publications (1)

Publication Number Publication Date
ES2087151T3 true ES2087151T3 (es) 1996-07-16

Family

ID=26988293

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90906530T Expired - Lifetime ES2087151T3 (es) 1989-03-31 1990-03-28 Preparacion de composiciones complejas de liposomas y lipidos.

Country Status (11)

Country Link
EP (1) EP0467954B1 (es)
JP (1) JP2798302B2 (es)
AT (1) ATE137403T1 (es)
AU (1) AU638245B2 (es)
CA (1) CA2050679C (es)
DE (1) DE69026820T2 (es)
DK (1) DK0467954T3 (es)
ES (1) ES2087151T3 (es)
HU (1) HU208070B (es)
NO (1) NO303205B1 (es)
WO (1) WO1990011780A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
FR2653015B1 (fr) * 1989-10-12 1993-10-29 Oreal Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
JP3074734B2 (ja) 1990-11-16 2000-08-07 日本新薬株式会社 分散製剤
DE4238779A1 (de) * 1992-11-12 1994-05-19 Max Delbrueck Centrum Lyotrophe Mesophasen und ihre Anwendung in der Pharmazie, der Kosmetik und der Dermatologie
DK0707472T3 (da) 1993-07-08 2001-04-17 Liposome Co Inc Fremgangsmåde til regulering af størrelsen af liposomer
DE69434623T2 (de) * 1993-09-29 2006-07-27 Dsm Ip Assets B.V. Modifizierte Formen des Natamycins, Verfahren zu ihrer Herstellung und sie enthaltende antifungale Zusammensetzungen
US5958901A (en) * 1995-06-07 1999-09-28 Genta Incorporated Phosphonic acid-based cationic lipids
AU773618B2 (en) * 1998-12-22 2004-05-27 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Water-insoluble drug delivery system
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
EP1334718A4 (en) * 2000-10-26 2007-07-18 Senju Pharma Co DRUG COMPOSITION CONTAINING DIPEPTIDYL ALDEHYDE COMPOUND
EP1343476B1 (en) * 2000-12-01 2008-05-28 Biomira Inc. Preparation of large liposomes by infusion into peg
IS6389A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
EP2146692A1 (en) * 2007-03-19 2010-01-27 Fresenius Kabi Oncology Limited Proliposomal and liposomal compositions
EP2219587A4 (en) * 2007-11-14 2012-11-21 Univ California STEROL-MODIFIED AMPHIPHILE LIPIDES
LT2344198T (lt) * 2008-09-27 2021-02-25 Jina Pharmaceuticals Inc. Farmaciniai preparatai lipidų pagrindu, skirti vietiniam naudojimui
CN102573889B (zh) * 2010-07-14 2014-10-22 中国医学科学院药物研究所 一种胰岛素的脂质复合物及其制备方法和制剂
EP3177269A4 (en) * 2014-08-04 2018-02-28 Zoneone Pharma, Inc. Remote loading of sparingly water-soluble drugs into lipid vesicles
CN113616798A (zh) * 2021-09-06 2021-11-09 天津农学院 一种甲苯咪唑脂质复合物、制备方法和应用
CN115177590A (zh) * 2022-04-20 2022-10-14 南昌大学抚州医学院 一种甲苯达唑类脂质体的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPS60240634A (ja) 1984-05-08 1985-11-29 関　則雄 飲み干し容易なコツプ
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity

Also Published As

Publication number Publication date
DK0467954T3 (da) 1996-05-28
HK1000912A1 (en) 1998-05-08
CA2050679A1 (en) 1990-10-01
AU5434590A (en) 1990-11-05
JPH04506207A (ja) 1992-10-29
CA2050679C (en) 1998-09-22
HUT59818A (en) 1992-07-28
EP0467954A1 (en) 1992-01-29
EP0467954A4 (en) 1992-06-03
DE69026820D1 (de) 1996-06-05
NO913816D0 (no) 1991-09-27
HU208070B (en) 1993-08-30
ATE137403T1 (de) 1996-05-15
AU638245B2 (en) 1993-06-24
JP2798302B2 (ja) 1998-09-17
DE69026820T2 (de) 1996-11-28
NO303205B1 (no) 1998-06-15
NO913816L (no) 1991-11-26
EP0467954B1 (en) 1996-05-01
WO1990011780A1 (en) 1990-10-18
HU903559D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
ES2087151T3 (es) Preparacion de composiciones complejas de liposomas y lipidos.
ES2107668T3 (es) Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
GR3020068T3 (en) Preparation of lipidic microparticles
CA1262093C (en) STEROID LIPOSOMES
ATE204469T1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
ATE52411T1 (de) Zubereitung von arzneimittelhaltigen lipidvesikeln und verfahren zu deren herstellung.
EP1419789A3 (en) Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these
ES2231819T3 (es) Particulas de lipido-acido nucleico preparadas a traves de un intermedio complejo de lipido-acido nucleico hidrofobo y uso para transferir genes.
NO964939D0 (no) Fremgangsmåte for fremstilling av virkestoffpreparater i form av en fast lösning av virkestoffet i en polymermatriks, samt virkestoffpreparater fremstilt ved hjelp av denne fremgangsmåte
ES2188750T3 (es) Procedimiento para la preparacion de particulas respirables.
ATE121301T1 (de) Mikrokristalle, die eine aktive substanz mit phospholipidischer affinität enthalten und mindestens ein phospholipid, verfahren zur herstellung.
NL300036I1 (nl) Liposomale formuleringen met een hoge anti-neoplastisch middel/lipideverhouding.
ES8600931A1 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
KR880009636A (ko) 리포좀 조성물 및 그의 제조방법
DE69414947T2 (de) Dialyselösung zur extrakorporalen Hemodialyse
ATE40292T1 (de) Verfahren zur herstellung von unilamellaren liposomen von grobem diameter, ihre pharmazeutische anwendung fuer die verkapselung von aktivem prinzip fuer die verzoegerte wirkstoffabgabe und vorrichtung hierfuer.
YU186791A (sh) Nove farmaceutske formulacije koje sadrže farmaceutski aktivnu jonizujuću supstancu, kao i postupak za njihovo dobijanje
GR3018064T3 (en) Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof.
AU2002340670A1 (en) Lipid carrier compositions and methods for improved drug retention
DE60103865D1 (de) Arzneizubereitungen und deren herstellungsverfahren
JPS58206597A (ja) 水性燐脂質溶液
ATE164759T1 (de) Herstellungsverfahren für teilchen in submikrongrösse in gegenwart von lipidvesikeln sowie die entsprechenden zusammensetzungen
SE9902742D0 (sv) New pharmaceutical formultion
JPS5675438A (en) Method for stabilizing aqueous solution of cyanocobalamin
JPH04270218A (ja) ビタミンａ含有リポソーム水懸濁液

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0467954

Country of ref document: ES